FDA inspection
Daiichi Sankyo Co., Ltd. Hiratsuka Plant: FDA inspection ending Apr 22, 2016
FDA inspection 971651 · Voluntary Action Indicated (VAI) · Hiratsuka
Key facts
| Inspection ID | 971651 |
|---|---|
| Firm | Daiichi Sankyo Co., Ltd. Hiratsuka Plant |
| FEI number | 3002808070 |
| Address | 1 Chome 12-1, Shinomiya |
| City | Hiratsuka |
| Country | Japan |
| Fiscal year | 2016 |
| Inspection end date | Apr 22, 2016 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data